Christopher DiSimone

1.3k citations
10 papers · 490 indexed · 1 hit paper · h-index 6
Topics
Cancer Immunotherapy and Biomarkers (5 papers)Endometrial and Cervical Cancer Treatments (5 papers)Ovarian cancer diagnosis and treatment (4 papers)

In The Last Decade

Christopher DiSimone

10 papers receiving 487 citations

Hit Papers

Lenvatinib Plus Pembrolizumab in Patients With Advanced E...20202026202220242020100200300

Peers

Christopher DiSimone
Comparison fields: 5 of 45
  • Oncology 271
  • Obstetrics and Gynecology 176
  • Pulmonary and Respiratory Medicine 148
  • Reproductive Medicine 133
  • Molecular Biology 114
Replace Cyril Abdeddaim with:
Cyril Abdeddaim France
A. De Jesus Acosta United States
S. Loibl Germany
Toshiko Minamoto Japan
Josep M. del Campo Spain
Mojca Persic United Kingdom
Haitham Arabi United States
Ulrich Canzler Germany
Ingirídur Skírnisdóttir Sweden
M F Brady United States
Christopher DiSimone relative to Cyril Abdeddaim France Cyril Abdeddaim's profile →
Citations per field
00.5×10×20×30×42×
Cyril Abdeddaim · 1×
Citations per year

Countries citing papers authored by Christopher DiSimone

Since Specialization
Citations

This map shows the geographic impact of Christopher DiSimone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher DiSimone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher DiSimone more than expected).

Fields of papers citing papers by Christopher DiSimone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher DiSimone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher DiSimone. The network helps show where Christopher DiSimone may publish in the future.

Co-authorship network of co-authors of Christopher DiSimone

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher DiSimone. A scholar is included among the top collaborators of Christopher DiSimone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher DiSimone. Christopher DiSimone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
#WorkIndexed citations
1 90
2 1
3
Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancerbreakdown →
359
4 2
5 7
6 9
7 9
8 3
9 6
10 4

About Christopher DiSimone

Christopher DiSimone is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Oncology, having authored 10 papers that have together received 490 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), Endometrial and Cervical Cancer Treatments (5 papers) and Ovarian cancer diagnosis and treatment (4 papers). The work is most often cited by research in Obstetrics and Gynecology (176 citations), Reproductive Medicine (133 citations) and Oncology (271 citations). Christopher DiSimone has collaborated with scholars based in United States, Spain and Czechia. Frequent co-authors include Emmett V. Schmidt, Matthew H. Taylor, Allen Lee Cohn, Daniel E. Stepan, Corina E. Dutcus, Robert Orlowski, Vicky Makker, Antonio Casado, Mark Messing and James W. Mier. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology and Gynecologic Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026